Global Wholehealth Partners Corp. (GWHP)

[dailystockexpert]

Global WholeHealth Partners Corp (GWHP-OTC) Acquires Rights to Distribute & Sell a 2nd COVID-19 Vaccine ( Pfizer-BioNTech )

Global WholeHealth Partners Corp Now Has the Rights to Distribute & Sell Both the Pfizer-BioNTech and J&J COVID-19 Vaccines.
Respectively, the Most Effective and the Most Convenient Vaccines.


Mr. Charles Strongo, the CEO and Chairman of WholeHealth Products Inc., said: “Global will now have both J&J’s extremely convenient 1-shot vaccine, and we now have the rights to the Pfizer-BioNTech vaccine, which is generally considered the highest efficacy.”


GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians' offices, and medical clinics in the US and abroad. The Company has the capacity to deliver hundreds of thousands of tests, and can ramp up to 1 million tests per day and the Company presently has 56 products FDA approved and many are Approved for OTC use, and 9 POC products approved by the FDA, many of which are Approved for OTC use, and 15 POC products approved by the CLIA WAIVED FDA.